» Articles » PMID: 33593710

The Dynamic Change of Antibody Index Against Covid-19 is a Powerful Diagnostic Tool for the Early Phase of the Infection and Salvage PCR Assay Errors

Abstract

Background: Currently, PCR assay is a golden standard for diagnosis of Covid-19. However, it needs nasopharyngeal swabs, expensive instruments and expertise. It even causes PCR errors.

Methods: We validated the antibody assay (Roche) in 36 followed patients and 1879 controls (medical staffs).

Results: Of 1879 medical staffs, only two (0.11%) were positive by Cut off Index (COI; 1.0) (mean ± SD, 0.094 ± 0.047). Thirty six patients were composed of three groups; Group A,4 from Diamond Princess cruise ship, Group B, 2 infected in Africa, and Group C, 30 infected in Japan. PCR assays were conducted at outside laboratories before and repeated in house after hospitalized. Of 36 at admission, positive antibody was seen in 4/4 from the ship, 0/2 from Africa, and 5/30 from Japan. Two from Africa showed the increase of COI and became positive on days 8 and 13. Thirty Japanese was divided in two groups, e.g., 23 showed dynamic increase of COI up to 84.4 within 3 days while active virus replication present (Group C). In remaining 7 (7/30, 23%) (Group C'), no rise of antibody nor positive in house PCR assays, indicative of false positive results of PCR at the beginning.

Conclusion: This antibody testing has a wide dynamic ranges of COI and, thus, could be utilized in the early infection phase. This may also compliment and even help to avoid possible PCR errors. Therefore, this can serve as a powerful diagnostic tool, needed in the frontline of the clinic and hospitals.

Citing Articles

Lung tropism in hospitalized patients following infection with SARS-CoV-2 variants from D614G to Omicron BA.2.

Hirotsu Y, Kakizaki Y, Saito A, Tsutsui T, Hanawa S, Yamaki H Commun Med (Lond). 2023; 3(1):32.

PMID: 36841870 PMC: 9959956. DOI: 10.1038/s43856-023-00261-5.


Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections.

Terreri S, Piano Mortari E, Vinci M, Russo C, Alteri C, Albano C Cell Host Microbe. 2022; 30(3):400-408.e4.

PMID: 35134333 PMC: 8820949. DOI: 10.1016/j.chom.2022.01.003.


Robust Antibody Responses to the BNT162b2 mRNA Vaccine Occur Within a Week After the First Dose in Previously Infected Individuals and After the Second Dose in Uninfected Individuals.

Hirotsu Y, Amemiya K, Sugiura H, Shinohara M, Takatori M, Mochizuki H Front Immunol. 2021; 12:722766.

PMID: 34512649 PMC: 8427169. DOI: 10.3389/fimmu.2021.722766.


Evaluation of the IgG antibody response to SARS CoV-2 infection and performance of a lateral flow immunoassay: cross-sectional and longitudinal analysis over 11 months.

Robertson L, Moore J, Blighe K, Ng K, Quinn N, Jennings F BMJ Open. 2021; 11(6):e048142.

PMID: 34187827 PMC: 8245291. DOI: 10.1136/bmjopen-2020-048142.


Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan.

Hirotsu Y, Omata M PLoS Pathog. 2021; 17(6):e1009619.

PMID: 34097716 PMC: 8238201. DOI: 10.1371/journal.ppat.1009619.


References
1.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

2.
Hirotsu Y, Maejima M, Shibusawa M, Nagakubo Y, Hosaka K, Amemiya K . Pooling RT-qPCR testing for SARS-CoV-2 in 1000 individuals of healthy and infection-suspected patients. Sci Rep. 2020; 10(1):18899. PMC: 7641135. DOI: 10.1038/s41598-020-76043-z. View

3.
Omata M, Yokosuka O, Takano S, Kato N, Hosoda K, Imazeki F . Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet. 1991; 338(8772):914-5. DOI: 10.1016/0140-6736(91)91774-o. View

4.
Omata M, Ehata T, Yokosuka O, Hosoda K, OHTO M . Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med. 1991; 324(24):1699-704. DOI: 10.1056/NEJM199106133242404. View

5.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View